To study the mechanisms underlying the development of interstitial pneumonia in autoimmune disease, we analyzed bronchoalveolar lavage fluid (BALF) in an animal model of interstitial pneumonia in which an intratracheal instillation of staphylococcal enterotoxin B (SEB) induced interstitial pneumonia in autoimmune-prone mice. Increases in the numbers of total cells, macrophages, lymphocytes, and neutrophils were observed in BALF from SEB-treated MRL ϩ / ϩ mice, and peaked at 3 d after SEB administration (Day 3). Flow cytometric analyses revealed increases in SEB-reactive V ␤ 8 ϩ T cells, indicating that SEBreactive cells play an important role in bronchoalveolar space. The expressions of tumor necrosis factor (TNF)-␣ , interferon (IFN)-␥ , JE/monocyte chemoattractant protein-1, regulated on activation, normal T cells expressed and secreted, and KC/gro messenger RNA (mRNA) in BALF cells from SEB-treated mice peaked at Day 3. Increased expression of TNF-␣ mRNA was observed mainly in macrophages and CD8 ϩ T cells, and the increase in IFN -␥ mRNA was observed mainly in CD8 ϩ T cells in BALF at Day 3. The expression of platelet-derived growth factor mRNA was very weak at Day 3 but strongly expressed at Day 14. An immunosuppressant, FK506, but not corticosteroid, suppressed SEB-induced T-cell expansion in BALF as well as increased cytokine and chemokine production in the bronchoalveolar space of SEBtreated mice. Histologically, FK506 but not corticosteroid significantly reduced both the cell infiltration to alveolar septal walls and the synthesis of pulmonary collagen fibers. Further, transfer of T cells of MRL ϩ / ϩ mice with SEB into SCID mice gave rise to interstitial pneumonia. These results suggest that superantigen-reactive T cells in the bronchoalveolar space may trigger the development of interstitial pneumonia in this model. (1, 2), and they have been recently suggested to participate in the development of various autoimmune diseases such as rheumatoid arthritis, insulin-dependent diabetes mellitus (IDDM), and psoriasis (3-5).
T cells, and the increase in IFN -␥ mRNA was observed mainly in CD8 ϩ T cells in BALF at Day 3. The expression of platelet-derived growth factor mRNA was very weak at Day 3 but strongly expressed at Day 14. An immunosuppressant, FK506, but not corticosteroid, suppressed SEB-induced T-cell expansion in BALF as well as increased cytokine and chemokine production in the bronchoalveolar space of SEBtreated mice. Histologically, FK506 but not corticosteroid significantly reduced both the cell infiltration to alveolar septal walls and the synthesis of pulmonary collagen fibers. Further, transfer of T cells of MRL ϩ / ϩ mice with SEB into SCID mice gave rise to interstitial pneumonia. These results suggest that superantigen-reactive T cells in the bronchoalveolar space may trigger the development of interstitial pneumonia in this model. Superantigens are extremely potent polyclonal mitogens that stimulate a large proportion of T cells expressing specific T-cell receptor (TCR) V ␤ s in both mice and humans (1, 2) , and they have been recently suggested to participate in the development of various autoimmune diseases such as rheumatoid arthritis, insulin-dependent diabetes mellitus (IDDM), and psoriasis (3) (4) (5) .
The pathogenesis and mechanisms underlying the development of interstitial pneumonia associated with autoimmune disease are not yet known (6, 7) . We have previously reported that an intratracheal instillation of superantigen induced interstitial pneumonia in autoimmune-prone mice but not in non-autoimmune-prone mice (8) . Because bronchoalveolar lavage fluid (BALF) can be used to demonstrate the pathophysiology of interstitial pneumonia to some degree (9, 10), we analyzed the BALF in our murine model of interstitial pneumonia. We found that the instilled superantigen, staphylococcal enterotoxin B (SEB)-reactive T cells, neutrophils, and alveolar macrophages significantly increased in BALF from MRL ϩ / ϩ mice injected with SEB 3 d previously (Day 3). A reverse transcriptase/polymerase chain reaction (RT-PCR) analysis in BALF from MRL ϩ / ϩ mice revealed early increases in messenger RNA (mRNA) of several chemokines and cy-tokines after the SEB administration. These results suggest that the instilled superantigen directly stimulated the resident cells in bronchoalveolar space and recruited inflammatory cells to the bronchoalveolar space and lung parenchyma around such spaces.
We also examined the effects of corticosteroid and FK506, immunosuppressive agents, to investigate immunologic events in the development of interstitial pneumonia in this animal model. Corticosteroid is a powerful antiinflammatory agent that alters the transcription of many genes (11, 12) . FK506 is a macrolide compound isolated from Streptomyces tsukubanesis and has potent immunosuppressive properties (13, 14) . In our present experiment, FK506 but not corticosteroid significantly suppressed SEB-induced T-cell expansions and resulted in the prevention of interstitial pneumonia. Further, interstitial pneumonia developed in SCID mice administered T cells from MRL ϩ / ϩ mice and SEB. These results indicate that superantigen-reactive T cells play a critical role in the initiation of interstitial pneumonia.
Materials and Methods

Antibodies and Reagents
Fluorescein isothiocyanate (FITC)-conjugated antimouse CD4 monoclonal antibody (mAb), FITC-conjugated antimouse CD8 mAb, biotin-conjugated antimouse CD8 mAb, biotin-conjugated antimouse V ␤ 6 TCR mAb, and biotinconjugated antimouse V ␤ 8 TCR mAb were purchased from PharMingen Co. (San Diego, CA). Antimouse macrophage mAb was purchased from BMA Biomedicals Ltd. (Augst, Switzerland). Streptavidin/R-phycoerythrin (Ancell Co., Bayport, MN) was used at a dilution of 1:25. Magnetic beads coated with antimouse CD4 mAb, antimouse CD8 mAb, or antirat immunoglobulin (Ig)G were purchased from Dynal A. S. (Oslo, Norway). SEB (Sigma Chemical Co., St. Louis, MO) was dissolved in phosphatebuffered saline (PBS) at 1 mg/ml. FK506 was generously supplied by Fujisawa Pharmaceutical Co. (Osaka, Japan). FK506 and prednisolone sodium succinate (Shionogi Co., Osaka, Japan) were dissolved in saline.
Mice
Female MRL ϩ / ϩ (H-2 k ), 12 wk of age, were purchased from SLC Japan, Inc. (Shizuoka, Japan). Female C.B-17 SCID mice, 6 to 8 wk of age, were purchased from CLEA Japan, Inc. (Tokyo, Japan). All mice were maintained in a specific pathogen-free environment at the Laboratory Animal Center of the Kumamoto University School of Medicine. SCID mice were housed in sterilized microbarrier units under germ-free conditions.
Administration of SEB
The administration of SEB into the tracheas of the MRL ϩ / ϩ mice was performed as previously described (8) . In brief, each mouse was anesthetized with an intraperitoneal injection of 0.34 to 0.42 ml (60 g/g body weight) of sodium pentobarbital (Abbott Laboratories, North Chicago, IL). After the trachea was exposed, a 27-gauge needle was inserted into the trachea and 40 g of SEB or 40 l of PBS was instilled on Day 0. BALF BALF was obtained from the lungs of mice that had received the intratracheal instillations of SEB 1, 3, 7, or 14 d previously. The mice were deeply anesthetized and killed by exsanguination of the abdominal aorta. After the chest was opened, a 20-gauge plastic catheter was inserted into the trachea and tied with 5-0 silk. The lungs from each animal were lavaged through a catheter with 1 ml of chilled PBS three times. The cells were pelleted by centrifugation and counted using a hemacytometer. Differential counts were performed on Diff-Quik-stained preparation. The rest of the pellets were used for the flow cytometric analysis or for the extraction of mRNA.
Flow Cytometry
Peripheral blood mononuclear cells (PBMCs) from SEBor PBS-treated mice were purified by gradient centrifugation using Lympholyte-M (Cedarlane, ON, Canada) and spleen cells were removed and treated with Tris-buffered 0.16 M ammonium chloride to lyse erythrocytes. Cells in BALF, spleen, lymph node, and PBMCs were stained with FITC-conjugated antimouse CD4 mAb or FITC-conjugated antimouse CD8 mAb together with biotinylated antimouse V ␤ 6 TCR mAb or antimouse V ␤ 8 TCR mAb, followed by incubation with streptavidin/R-phycoerythrin. The cell analysis was performed on a FACScan flow cytometer (Becton Dickinson Co., San Francisco, CA).
RT-PCR
The extraction of mRNA was performed from the isolated macrophages, CD4 ϩ T cells, and CD8 ϩ T cells in BALF, as well as the whole cells in BALF. To separate macrophages, CD4
ϩ and CD8 ϩ T cells and BALF cells were incubated with the magnetic beads coated with anti-CD4 mAb or anti-CD8 mAb, or were incubated with rat antimouse macrophage mAb followed by the addition of magnetic beads coated with antirat IgG Ab, and isolated with a magnetic field generated by a magnetic particle concentrator (Dynal A. S.). mRNA was directly extracted from the 
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cells of BALF using a Micro-Fasttrack mRNA isolation kit (Invitrogen, San Diego, CA). A total of 1 g of mRNA was reverse transcribed into complementary DNA (cDNA) using an oligo(dT) [12] [13] [14] [15] [16] [17] [18] primer (GIBCO BRL, Rockville, MD) and moloney murine leukemia virus RT (GIBCO BRL) in a 20-l reaction, followed by PCR amplification. Each reaction contained 1 l of cDNA, 500 nM of each primer (Table 1) , 200 mM of each of the four deoxynucleotide triphosphates, 1.5 mM MgCl 2 , and 1.25 U of DNA polymerase, AmpliTaq (Perkin-Elmer, Foster City, CA) in a final volume of 50 l reaction mixture. After a 2-min initial denaturing at 94 Њ C, 33 or 35 cycles of denaturation (94 Њ C) for 60 s, annealing (55 Њ C) for 60 s, and extension (72 Њ C) for 90 s were conducted. As an internal control, ␤ -actin was amplified to normalize the starting amount of cDNA for each sample. The optimal numbers of PCR cycles for exponential amplification were 33 for ␤ -actin and 35 for other cytokines and chemokines. Aliquots of the PCR reaction products (10 l) were electrophoresed on 2% agarose gels and visualized by ethidium bromide staining and ultraviolet transillumination. The resulting images were density-scanned (FAS-II; Toyobo, Osaka, Japan). Band intensities were determined by use of the NIH image 1.61 program (Wayne Rasband Analytics; National Institutes of Health, Bethesda, MD) and the cytokine or chemokine to ␤ -actin ratios were calculated.
Histology
Lung tissue was removed 7 d after intratracheal instillation of SEB, and fixed-inflated to 20 to 23 cm H 2 O pressure with 10% formalin. After fixation, all lobes of the lung were sectioned by sagittal cuts. The tissue specimens were set in paraffin blocks, sectioned, and stained with hematoxylin and eosin (H&E) and azan. The slides of lung tissue were analyzed by a previously published method (8) .
Categories of histopathologic findings were as follows: ( 1 ) increased cellularity into the alveolar septal walls, ( 2 ) inflammatory cell accumulation in the periarterial space, and ( 3 ) increase in pulmonary interstitial collagen fibers. Semiquantitative scoring was as follows: 0 = no change; 1 = slight change; 2 ϭ moderate change; 3 ϭ marked change; and 4 ϭ severe change.
Enzyme-Linked Immunosorbent Assay
Tumor necrosis factor (TNF)-␣ , interferon (IFN)-␥ , and interleukin (IL)-2 in BALF from SEB-or PBS-treated MRL ϩ / ϩ mice were detected by enzyme-linked immunosorbent assay (ELISA) kits (Biosource International, Camarillo, CA), following the manufacturer's instructions. The sensitivity of each ELISA kit was as follows: TNF-␣ , Ͻ 3.0 pg/ml; IFN -␥ , Ͻ 1.0 pg/ml; and IL-2, Ͻ 13 pg/ml.
Administration of FK506 and Prednisolone
MRL ϩ / ϩ mice were intraperitoneally injected with saline (saline group), FK506 (10 mg/kg/d; FK506 group), or prednisolone sodium succinate (2 mg/kg/d; prednisolone group) daily from the day before SEB administration to Day 3 or 7. The dosage regimen of FK506 was comparable to those used in previous studies (15, 16) .
In Vitro Assay for Immunosuppressive Activity of FK506 and Prednisolone
Spleen cells from the nonstimulated MRL ϩ / ϩ mice were treated with Tris-buffered 0.16 M ammonium chloride and cultured with 10 g/ml SEB for 72 h in RPMI 1640 medium containing penicillin G (100 U/ml), streptomycin (100 g/ml), 10% heat-inactivated fetal calf serum, and 2-mercaptoethanol (50 m) in a 96-well culture plate at 10 5 cells/100 l (8, 17) in the presence of FK506 or prednisolone. A total of 10 l of TetraColor One (5 mM tetrazolium monosodium sodium and 0.2 mM 1-methoxy-5-methylphenazinium methylsulfate; Seikagaku Corp., Tokyo, Japan) was added to each well and incubated for the final 4 h, and the plate was analyzed on an ELISA reader at 450 nm.
Cell Transfer into SCID Mice by Intratracheal Injection
Spleen T cells, T cell-depleted spleen cells, or BALF cells from untreated MRL ϩ / ϩ mice were intratracheally injected into the lung of SCID mice with 40 g of SEB. For T-cell purification, spleen cells treated with ammonium chloride were cultured on plastic dishes, then nonadherent cells were recovered and subjected to nylon wool columns ( Ͼ 95% CD3 ϩ T cells) (18) . For T-cell removal, spleen cells were incubated with magnetic beads coated with anti-CD4 mAb and anti-CD8 mAb, then removed by magnetic extraction ( Ͻ 2% CD3 ϩ T cells). A total of 5 ϫ 10 5 cells of each group, suspended in 30 l of minimum essential medium (MEM) was transferred into SCID mice. At 7 or 14 d after the cell transfer, SCID mice were killed and subjected to histopathologic examination.
Statistical Analysis
The values shown are means Ϯ standard error of the mean (SEM). The statistical analysis was performed using the unpaired Student's t test. P values less than 0.05 were considered significant.
Results
Characterization of Cells in BALF
As indicated in Figure 1 , more than 98% of the cells in BALF from the PBS-treated MRL ϩ/ϩ mice were macrophages. In BALF from the SEB-treated mice, the numbers of total cells, macrophages, lymphocytes, and neutrophils increased significantly, and peaked 3 d after the SEB administration. A slight increase in neutrophils was seen at Day 1 (data not shown).
The fluorescence-activated cell sorter (FACS) analysis of BALF cells from the SEB-treated mice showed CD8 ϩ T cells to be more abundant than CD4 ϩ T cells, and the ratio of CD4/CD8 was 0.32 Ϯ 0.12 at Day 3. An increase in SEB-reactive V␤8 ϩ T cells was seen in both CD4 ϩ and ϩ T cells expressing TCR V␤8 (Table 2 ). In PBMCs and lymph nodes, similar results were seen (data not shown).
Cytokine and Chemokine mRNA Expression of BALF Cells
We analyzed the cytokine and chemokine mRNA expressions in BALF cells by RT-PCR. The TNF-␣ and IFN-␥ mRNA levels in the SEB-treated mice were elevated at Day 3 compared with the PBS-treated mice, and then decreased at Day 14 ( Figure 3A) . The increase in mRNA expression of TNF-␣ was observed mainly in macrophages and CD8
ϩ T cells, and increased mRNA expression of IFN-␥ was seen mainly in CD8 ϩ T cells 3 d after SEB administration ( Figure 3B ). The expression of JE/monocyte chemoattractant protein (MCP)-1, regulated on activation, normal T cells expressed and secreted (RANTES), and transforming growth factor (TGF)-␤ mRNA was detected at Day 3 and continued for 14 d in the SEB-treated mice. The peak of expression of platelet-derived growth factor (PDGF) mRNA was seen at Day 14 ( Figure 3A ).
The expression of IL-4 and IL-5 mRNA did not increase at Day 3 or 14 (data not shown). In BALF 24 h after the SEB administration, slight increases in the mRNA expressions of TNF-␣ and KC/gro were seen, but there was no increase in the mRNA of other cytokines or chemokines (data not shown).
Effects of FK506 and Prednisolone In Vivo
To examine the effects of FK506 and prednisolone on SEB-induced interstitial pneumonia, mice were intraperitoneally injected with saline, FK506, or prednisolone daily. In the BALF from the FK506 group, the increases in the numbers of total cells, macrophages, lymphocytes, and neutrophils were inhibited at both Day 3 and Day 7 (Figure 4) . The mRNA expressions of TNF-␣, IFN-␥, TGF-␤, RANTES, and JE/MCP-1 at Day 3 and those of RANTES, JE/MCP-1, and PDGF at Day 7 were significantly suppressed by FK506 treatment ( Figure 5 and Table 3 ). The mean values of TNF-␣, IFN-␥, and IL-2 in BALF at Day 3 detected by ELISA were also suppressed by FK506 treatment ( Figure 6 ). In BALF 24 h after SEB administration, there were no increases in the values of TNF-␣, IFN-␥, and IL-2 (data not shown). Histopathologically, FK506 significantly reduced both the cell infiltration into the alveolar septal walls and the synthesis of pulmonary collagen fibers; however, it did not reduce the inflammatory cell accumulation in the periarterial space (Figures 7 and  8 ). In contrast, prednisolone had no effect on the BALF or histologic findings (Figures 4, 7, and 8) . 
Analysis of Immunosuppressive Activity of FK506 and Prednisolone In Vitro Assay
We compared the immunosuppressive effects of FK506 and prednisolone in vitro on SEB-induced spleen cell proliferation. FK506 inhibited the proliferation of spleen cells at the concentration of 0.1 ng/ml, whereas prednisolone required 100 ng/ml. In in vitro assay, prednisolone was approximately 1,000-fold less effective than FK506 in preventing SEB-induced spleen cell expansion ( Figure 9 ).
After 72 h stimulation of spleen cells with SEB (10 g/ml), the CD4 ϩ
/CD8
ϩ ratio was 0.88 and the percentages of CD4
ϩ T cells and CD8 ϩ V␤8 ϩ /CD8 ϩ T cells were 39.4 and 51.7%, respectively, indicating the decrease in the CD4 ϩ /CD8 ϩ ratio and the increase of proportions of V␤8 ϩ T cells in both CD4 ϩ and CD8 ϩ T cells compared with freshly isolated spleen cells from nontreated and PBS-treated MRL ϩ/ϩ mice (data not shown and Table 2 ).
Induction of Interstitial Pneumonia in SCID Mice
FK506 is known to act on other types of cells, such as macrophages and neutrophils, as well as T cells (19) . Inasmuch as FK506 suppressed the induction of interstitial pneumonia, next we transferred T cells of MRL ϩ/ϩ mice and SEB into SCID mice and examined whether the interstitial pneumonia developed to further investigate the role of T cells in this animal model. In SCID mice administered T cells from MRL ϩ/ϩ mice and SEB, the cell accumulation into the perivascular space and the alveolar septal walls was seen. The synthesis of pulmonary collagen fibers was also detected, though the degree of it was weaker than that of SEB-treated MRL ϩ/ϩ mice. In SCID mice injected with T cell-depleted spleen cells and SEB, or BALF cells and SEB, no histologic change was observed. Although slight accumulation of inflammatory cells into the perivascular space was seen in SCID mice injected with spleen T cells without SEB, there was a significant difference in the degree of histopathologic change between this group and the group injected with T cells and SEB (Figures 10 and 11 ).
Discussion
Superantigens are produced by many different pathogens, including bacteria, mycoplasma, and viruses (2, 20) . Superantigens bind to both specific V␤ segments of TCR and major histocompatibility complex molecules without being processed and stimulate very large numbers of T cells (1) . The recently discovered selective expansion of T cells bearing specific TCR V␤s in the synovial fluid of rheumatoid arthritis patients and islet of IDDM patients has suggested that superantigens participate in the development of various autoimmune diseases (3, 4) .
In the present study, we analyzed the BALF in our murine model of interstitial pneumonia. Significant increases in the numbers of macrophages, lymphocytes, and neutrophils peaking 3 d after SEB treatment were observed. The analysis of the TCR V␤ of infiltrated lymphocytes in BALF from SEB-treated MRL ϩ/ϩ mice revealed expansions in SEB-reactive CD8 ϩ
V␤8
ϩ T cells. On the other hand, CD8
ϩ V␤8 ϩ T cell number was decreased in spleen 3 d after SEB administration compared with PBS-treated mice. The stainings of spleen cells at Day 3 with anti-V␤8 mAb and Annexin V showed no significant increase in the proportion of apoptotic V␤8 ϩ T cells (data not shown). These results suggest recruitment of CD8 ϩ
ϩ T cells to lung tissue. Further, when the spleen cells were stimulated with SEB, CD8 ϩ V␤8 ϩ T cells propagated much more than did CD4 ϩ
ϩ T cells (data not shown). The accumulation of CD8 ϩ
ϩ T cells in bronchoalveolar space after SEB administration may be due to proliferation of SEBreactive T cells in bronchoalveolar space as well as to recruitment. The higher susceptibility of CD8 ϩ T cells to SEB-induced T-cell proliferation than CD4 ϩ T cells (data not shown) may contribute to the increase of CD8 ϩ T cells in bronchoalveolar space. We also observed early increases in the expression of TNF-␣, IFN-␥, JE/MCP-1, RANTES, KC/gro, and TGF-␤ mRNA in BALF cells. Further, mRNA expression of cytokines and chemokines was mainly increased in CD8 ϩ T cells as well as in macrophages in BALF. Nagai and Izumi previously reported increases in CD8 ϩ T cells in BALF from patients with autoimmune diseases (7) . Although the role of accumulated CD8 ϩ T cells in the bronchoalveolar space of this animal model has not been elucidated, we found that these CD8 ϩ T cells produce proinflammatory cytokines and they may participate directly in the process of tissue destruction by several death systems, such as the CD95-CD95 ligand system. These results indicate that instilled SEB may first stimulate resident SEB-reactive T cells and some macrophages (21) in the bronchoalveolar space, and that these cells strongly proliferate and/or produce several proinflammatory cytokines and chemokines, resulting in the recruitment of several types of inflammatory cells to the lung.
TNF-␣ mRNA was detected mainly in CD8 ϩ T cells and macrophages at Day 3 in our model. TNF-␣ is a cytokine with both inflammatory and fibrogenic activities (22) . TNF-␣ mRNA and protein have been detected in lungs from patients with idiopathic pulmonary fibrosis (IPF) Figure 8 . The effect of FK506 and prednisolone on histopathologic findings. Lung tissue obtained from the saline-, FK-, and prednisolone-treated mice at Day 7 was analyzed for the three categories and scoring system as described in MATERIALS AND METHODS. FK506 suppressed both cell infiltration into the alveolar septal walls (A) and the synthesis of pulmonary collagen fibers (C), but not the inflammatory cell accumulation in periarterial space (B). Each data point represents an individual mouse. *P Ͻ 0.05 versus the saline group. Figure 9 . In vitro assay for immunosuppressive activity of FK506 and prednisolone. Spleen cells from nontreated MRL ϩ/ϩ mice were cultured for 72 h with SEB (10 g/ml) in the presence of FK506 or prednisolone. The suppressive effect of FK506 and prednisolone on SEB-induced spleen cell proliferation was analyzed with an ELISA reader at 450 nm after coincubation with TetraColor One. Data are means of triplicated samples Ϯ SEM. (23) and lungs from mice with pulmonary fibrosis elicited by exposure to bleomycin or silica (24) (25) (26) . In these experimental models, pulmonary inflammation and fibrosis were prevented by the injection of anti-TNF-␣ Ab or TNF-␣ antagonist. In both our SEB-induced interstitial pneumonia and bleomycin-induced interstitial pneumonia models, the TNF-␣ mRNA expression was fairly low on Day 14. These results indicate that TNF-␣ may play an important role in the development of interstitial pneumonia, especially in the acute phase after onset. IFN-␥ was released mainly by CD8 ϩ T cells in the BALF cells from SEB-treated mice. It enhances the accessory function of antigen-presenting cells (27) and behaves as an antifibrogenic factor with suppressive effects on the production of extracellular proteins (28) . However, IFN-␥'s contribution to the anti-fibrogenic potency in our animal model seems to be small inasmuch as IFN-␥ mRNA decreased at Day 14. It is known that IFN-␥ upregulates the expression of CD95 (29) , resulting in an augmentation of apoptosis. The role of IFN-␥ in the bronchoalveolar space is very complicated, and the role of IFN-␥ in apoptosis in the bronchoalveolar space has not been elucidated.
PDGF and insulin-like growth factor (IGF)-I are growth factors for fibroblasts and epithelial cells, and their receptors are abundantly expressed in the lungs of IPF patients (30) (31) (32) . Increased expressions of PDGF and IGF-I mRNA in BALF cells from bleomycin-treated mice were observed (33) . Although PDGF seems to play an important role in the pulmonary fibrosis in our animal model, the reasons why the increase in PDGF mRNA persists in relatively late phase is not clear. It is necessary to clarify the regulation of the transcription of the PDGF gene in our animal model. FK506 binds to the intracellular FK-binding protein (34) . This complex binds to the serine/threonin-specific phosphatase calcineurin, preventing its activation by calcium and blocking activation of the cytoplasmic nuclear factor of activated T-cell proteins (35, 36) . In the present study, FK506 but not corticosteroid blocked clonal expansion of SEB-reactive T cells in BALF and it suppressed TNF-␣, IFN-␥, JE/MCP-1, RANTES, and PDGF mRNA expression in BALF cells, resulting in the prevention of the development of interstitial pneumonia in SEB-treated MRL ϩ/ϩ mice. Although corticosteroids are widely used in the treatment of IPF and other fibrotic lung disorders, they result in favorable clinical response in only one-fourth to one-third of patients with IPF (37) , and the effects of corticosteroids have been achieved in only 15 to 30% of cases in pulmonary complications of autoimmune disease (6) . In our experiment, corticosteroid treatment had no effect on the mRNA expression of cytokines and chemokines, or on histologic findings. Flow cytometric analysis revealed that the expansion of SEB-reactive T cells in BALF was not inhibited by corticosteroid treatment (data not shown). In in vitro assay, prednisolone was approximately 1,000-fold less effective than FK506 in prevention of SEB-induced proliferation of spleen cells. These data suggest that corticosteroid does not suppress the initiation of SEB-induced inflammation and subsequent induction of interstitial pneumonia. Differences in the actions of and corticosteroid in this model might be due to different immunologic actions and dosages.
To clarify the role of T cells in this model, we transferred each type of cell of MRL ϩ/ϩ mice into SCID mice with SEB. Transfer of T cells and SEB was necessary for the development of interstitial pneumonia in SCID mice. These results support the ideas that SEB-induced T-cell expansion may trigger the induction of interstitial pneumonia and that T cells play an important role in this model (although we never exclude the role of other types of cells, such as macrophages and neutrophils).
The mechanism of development of interstitial pneumonia is very complicated. In this study, we demonstrated that SEB-induced T-cell expansion plays an important role in initiation of interstitial pneumonia in our model. Further studies are needed to clarify the mechanisms underlying the development of interstitial pneumonia in this animal model, and the results obtained should contribute to our understanding of human lung fibrosis.
